CMP
Coston McIsaac & Partners’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45K | Hold |
1,189
| – | – | 0.01% | 316 |
|
|
2025
Q1 | $46K | Hold |
1,189
| – | – | 0.01% | 282 |
|
|
2024
Q4 | $40K | Hold |
1,189
| – | – | 0.01% | 311 |
|
|
2024
Q3 | $48 | Hold |
1,189
| – | – | 0.01% | 284 |
|
|
2024
Q2 | $45K | Hold |
1,189
| – | – | 0.01% | 276 |
|
|
2024
Q1 | $50K | Hold |
1,189
| – | – | 0.02% | 267 |
|
|
2023
Q4 | $44K | Hold |
1,189
| – | – | 0.02% | 279 |
|
|
2023
Q3 | $43K | Hold |
1,189
| – | – | 0.02% | 257 |
|
|
2023
Q2 | $42K | Hold |
1,189
| – | – | 0.01% | 296 |
|
|
2023
Q1 | $42K | Hold |
1,189
| – | – | 0.02% | 289 |
|
|
2022
Q4 | $41 | Hold |
1,189
| – | – | 0.02% | 298 |
|
|
2022
Q3 | $34K | Sell |
1,189
-295
| -20% | -$8.44K | 0.02% | 273 |
|
|
2022
Q2 | $65K | Buy |
+1,484
| New | +$65K | 0.04% | 117 |
|